Life Science Index
| Index | Dec Value | Change 12 mo. | 12 mo. High | 12 mo. Low |
| . EC BioTools | 532 | -15% | 722 | 532 |
| . EC BigPharma | 884 | 9% | 934 | 818 |
| . EC Biotech | 647 | 10% | 734 | 602 |
January, 2012 Update
It was a relatively calm end to the year with all indices moving slightly. Nothing noteworthy with the Tools sector as declines led advances 2 to 1. In BigPharma, Lilly, BMS and Pfizer were up 8-10% and nearly all the others were up as well, raising the index 3% for the month. Biotech, as usual, was more volatile with shares wagging plus or minus 5-10% for a net change of ~0% for the index. The big loser was Intermune off 31% for the month after the German health agency said their lung-disease drug, Esbriet, offered little benefit to patients.
EC BioIndex
- Many of the life science indices currently available are a mixture of various types of companies. In order to better assess the situation in the different segments, Eastwoods Consulting has created these price-weighted indices for the sectors of large pharmaceutical companies, biotech companies, and life science research tools companies.
- EC BioTools Index – A, ACCL, AFFX, BIO, BRKR, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL, TECH, TMO, WAT
- EC BigPharma Index – JNJ, PFE, GSK, NVS, SNY, LUN, ABT, LLY, AZN, WYE, BMY, NVO, BAX, TEVA, VRX.TO, ROG.VX
- EC Biotech Index – ALKS, AMGN, AMLN, BIIB,BMRN, CPHD, DNDN, GILD, HGSI, IDXX, ITMN, NKTR, PDLI, REGN, SGMO, SHPGY, THRX, VRTX
- Prices are taken at the close of each month.